<code id='59B5DE6F83'></code><style id='59B5DE6F83'></style>
    • <acronym id='59B5DE6F83'></acronym>
      <center id='59B5DE6F83'><center id='59B5DE6F83'><tfoot id='59B5DE6F83'></tfoot></center><abbr id='59B5DE6F83'><dir id='59B5DE6F83'><tfoot id='59B5DE6F83'></tfoot><noframes id='59B5DE6F83'>

    • <optgroup id='59B5DE6F83'><strike id='59B5DE6F83'><sup id='59B5DE6F83'></sup></strike><code id='59B5DE6F83'></code></optgroup>
        1. <b id='59B5DE6F83'><label id='59B5DE6F83'><select id='59B5DE6F83'><dt id='59B5DE6F83'><span id='59B5DE6F83'></span></dt></select></label></b><u id='59B5DE6F83'></u>
          <i id='59B5DE6F83'><strike id='59B5DE6F83'><tt id='59B5DE6F83'><pre id='59B5DE6F83'></pre></tt></strike></i>

          leisure time

          leisure time

          author:hotspot    Page View:17643
          Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT
          Adobe

          Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

          The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

          advertisement

          The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          A double vaccine crisis is endangering millions of children
          A double vaccine crisis is endangering millions of children

          AdobeWorldhealthexpertsmetrecentlytodiscussanemergingglobalhealthcrisislinkedtotheCovid-19pandemic:p

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          No plane should take off without an EpiPen onboard

          Anaphylaxisisalife-threateningmedicalemergencyandhastobetreatedwithepinephrine,sometimesdeliveredthr